Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Favrot

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Therapie|November 7, 1998
[Gene therapy: a review 6 years after the first trials in man. Round Table No 6 at Giens XIII]M C Favrot
Pathologie-Biologie|January 1, 1988
[Why a growing interest in cancerology for residual disease? Is bone marrow a preferential site for detection?]M C Favrot
La Revue Du Praticien|May 1, 1997
[The cancerous cell. Genetic abnormalities (oncogenes and anti-oncogenes), growth factors, apoptosis and dissemination factors, prognostic incidence]M C Favrot
Human Gene Therapy|June 1, 1992
Retroviral gene therapy and its application in oncohematologyY Merrouche, M C Favrot
Human Gene Therapy|October 1, 1992
Treatment of patients with advanced cancer using tumor infiltrating lymphocytes transduced with the gene of resistance to neomycinM C Favrot, T Philip
Bone Marrow Transplantation|August 1, 1987
Detection of minimal malignant cell infiltration in the bone marrow of patients with solid tumours, non-Hodgkin lymphomas and leukaemiasM C Favrot, P Hervé
La Revue Du Praticien|November 1, 1993
[Neuroblastoma. Current clinical and therapeutic aspects. Contributions of modern biology]O Hartmann, M C Favrot
Advances in Experimental Medicine and Biology|February 23, 1999
Application of gene transfer in cancer immunotherapy. From experimental data to clinical protocolsM C Favrot, I Puisieux
Pathologie-Biologie|February 1, 1989
Monoclonal antibodies in cancer therapyM C Favrot, V Combaret, T Philip
The New England Journal of Medicine|December 23, 1993
CD44--a new prognostic marker for neuroblastomaM C Favrot, V Combaret, C Lasset
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Therapie|November 7, 1998
[Gene therapy: a review 6 years after the first trials in man. Round Table No 6 at Giens XIII]M C Favrot
Pathologie-Biologie|January 1, 1988
[Why a growing interest in cancerology for residual disease? Is bone marrow a preferential site for detection?]M C Favrot
La Revue Du Praticien|May 1, 1997
[The cancerous cell. Genetic abnormalities (oncogenes and anti-oncogenes), growth factors, apoptosis and dissemination factors, prognostic incidence]M C Favrot
Human Gene Therapy|June 1, 1992
Retroviral gene therapy and its application in oncohematologyY Merrouche, M C Favrot
Human Gene Therapy|October 1, 1992
Treatment of patients with advanced cancer using tumor infiltrating lymphocytes transduced with the gene of resistance to neomycinM C Favrot, T Philip
Bone Marrow Transplantation|August 1, 1987
Detection of minimal malignant cell infiltration in the bone marrow of patients with solid tumours, non-Hodgkin lymphomas and leukaemiasM C Favrot, P Hervé
La Revue Du Praticien|November 1, 1993
[Neuroblastoma. Current clinical and therapeutic aspects. Contributions of modern biology]O Hartmann, M C Favrot
Advances in Experimental Medicine and Biology|February 23, 1999
Application of gene transfer in cancer immunotherapy. From experimental data to clinical protocolsM C Favrot, I Puisieux
Pathologie-Biologie|February 1, 1989
Monoclonal antibodies in cancer therapyM C Favrot, V Combaret, T Philip
The New England Journal of Medicine|December 23, 1993
CD44--a new prognostic marker for neuroblastomaM C Favrot, V Combaret, C Lasset
Pageof 8